Top PDF Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer.
Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer.
... radiography with or without chest ...procedure. In all patients, visual inspection of the larynx, vocal cords, trachea, carina, and all segmental orifices of both lungs was ...bronchoscope, ...
7
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
... noted in its phase I and II trials, with rash and diarrhea as the most common adverse ...gefitinib in patients with locally advanced or metastatic NSCLC after failure of at least one ...
11
Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.
... limitations in the study. Firstly, as only few data of patients with NSCLC were available for analysis and other data such as HRs for OS based on histology, gender, and age were not mentioned ...
12
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
... role in regulating multiple cellular processes including proliferation, differentiation, cell migration and cell ...associated with the development of a variety of human malignancies including ...
22
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
... listed in Table 3. Additionally, a longer SPP time was associated with several clinical Figure ...trends in survival data. A. Trend in survival times in advanced NSCLC ...
8
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... importance in cancer initiation and ...many cancer types, including lung can- ...on cancer progression and treatment efficacy have remained ...morphisms with clinical outcome of ...
13
THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
... Lung cancer remains the most common cause of can- cer death worldwide for both men and ...all lung cancer cases ...of patients diagnosed with NSCLC present at diagnosis ...
5
Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.
... only in full ...included in the article or extrapolated from the survival curves, which involves making ...assumptions. In addition, each study adjusted for different covariates and only the ...
8
Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN
... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ...the ...
102
J. bras. pneumol. vol.42 número5
... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ...the ...
9
J. bras. pneumol. vol.30 número1 en v30n1a03
... studied patients with non-small cell lung cancer who underwent surgical curative resection between January 1, 1990 and December 31, 1997 at the Pontifícia Universidade Católica ...
8
Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer
... Fig 1 Multivariate analysis shows weight loss before treatment (A), ECOG score (B), EGFR-TKI treatment (C) and response of first-line chemotherapy (D) are independent prognostic factors for female patients ...
6
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
... like patients with an EGFR activation mutation, impressive im- provements in the treatment of lung cancer patients were achieved ...for patients with advanced stage ...
10
Rev. Hosp. Clin. vol.56 número2
... For patients with non-small cell lung cancer (NSCLC), the prospect of long-term survival is directly related to the surgical resectability of the primary ...of ...
6
Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.
... tumor cell vaccine raised a question of whether and to what extent is the T cell immunity provoked by systemic injection of tumor cell vaccine enriches in the tumor microenvironment to ...
7
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
... inflammation, cancer can induce local or systemic inflammation, which is mediated by activation of transcription factors and production of major inflammatory cyto- kines ...hand, cancer-related inflammation ...
14
Rev. bras. epidemiol. vol.17 número4
... Non-Small Cell Lung Cancer (NSCLC) are scarce with regard to the private health care in ...the survival of patients with NSCLC in a Brazilian private ...
14
Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.
... 2008, patients who were newly diagnosed HCC and received RFA as initial treatment in Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center (Guangzhou, China) were retrospectively ...
11
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.
... all patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) eventually develop acquired resistance to EGFR tyrosine kinase inhibitors ...
13
Clinics vol.66 número11
... one patients were enrolled in the study. All of the patients were submitted to surgical procedures for diagnosis and treat- ment which were performed within 30 days after chest CT and ...team ...
9
